Free · No signup · Updated daily
In Brief
Identifies India among 23 nations in its annual Major Illicit Drug Producing and Transit Countries determination.
The United States Presidential Determination designated India alongside 22 other countries, including Pakistan and China, as a 'Major Illicit Drug Producing or Major Drug Transit Country' for 2026. However, US President Donald Trump acknowledged India's proactive law enforcement measures and government crackdowns on illegal poppy farming and synthetic narcotics precursor chemical supply chains.
Under the US Foreign Assistance Act (FAA) of 1961, the US President is required annually to identify foreign nations that significantly impact the US drug ecosystem. Inclusion on the list does not automatically imply a sanction, provided the country demonstrates continuous compliance with international counter-narcotics treaties.
The 23-nation list highlights critical global transit routes for synthetic opioids like fentanyl, heroin, and methamphetamine precursors. India's legal pharmaceutical sector and geographical proximity to the Golden Crescent (Iran-Afghanistan-Pakistan) and Golden Triangle (Myanmar-Laos-Thailand) contribute to its exposure as a transit node under NDPS Act monitoring.
The report underlines complex international counter-narcotics governance and cross-border security challenges. For aspirants, this topic connects with GS Paper III (Internal Security, Transnational Organised Crime, Golden Triangle/Crescent) and GS Paper II (Bilateral Relations).
India Rejects Joint Pakistan-China Boundary Commission Over PoK
17 Sep 2026
Tanker El Gaia Hit in Strait of Hormuz Operating in Maritime 'Dark Mode'
16 Sep 2026
BRICS Summit Adopts New Delhi Declaration Condemning Pahalgam Terror Attack
16 Sep 2026
India Approves Export of 654 MW Electricity to Flood-Hit Nepal Till December 31
15 Sep 2026